nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—SLC6A3—attention deficit hyperactivity disorder	0.494	0.572	CbGaD
Venlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.369	0.428	CbGaD
Venlafaxine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0111	0.213	CbGeAlD
Venlafaxine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.0059	0.113	CbGeAlD
Venlafaxine—SLC6A3—Clearance of dopamine—COMT—attention deficit hyperactivity disorder	0.00432	0.0545	CbGpPWpGaD
Venlafaxine—SLC6A3—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.00429	0.0541	CbGpPWpGaD
Venlafaxine—NPY1R—forebrain—attention deficit hyperactivity disorder	0.00405	0.0778	CbGeAlD
Venlafaxine—Desvenlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.00374	0.627	CrCbGaD
Venlafaxine—SLC6A4—Serotonin Transporter Activity—TPH2—attention deficit hyperactivity disorder	0.00331	0.0418	CbGpPWpGaD
Venlafaxine—Tramadol—SLC6A4—attention deficit hyperactivity disorder	0.00222	0.373	CrCbGaD
Venlafaxine—NPY1R—nervous system—attention deficit hyperactivity disorder	0.0022	0.0423	CbGeAlD
Venlafaxine—NPY1R—central nervous system—attention deficit hyperactivity disorder	0.00212	0.0407	CbGeAlD
Venlafaxine—SLC6A4—Serotonin Transporter Activity—MAOA—attention deficit hyperactivity disorder	0.00199	0.0251	CbGpPWpGaD
Venlafaxine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00197	0.0249	CbGpPWpGaD
Venlafaxine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00196	0.0247	CbGpPWpGaD
Venlafaxine—SLC6A3—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.00186	0.0234	CbGpPWpGaD
Venlafaxine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.0017	0.0328	CbGeAlD
Venlafaxine—NPY1R—brain—attention deficit hyperactivity disorder	0.00168	0.0323	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00158	0.0199	CbGpPWpGaD
Venlafaxine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00156	0.03	CbGeAlD
Venlafaxine—SLC6A4—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00141	0.0178	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00139	0.0175	CbGpPWpGaD
Venlafaxine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00137	0.0264	CbGeAlD
Venlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00131	0.0165	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00121	0.0153	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00119	0.015	CbGpPWpGaD
Venlafaxine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00113	0.0216	CbGeAlD
Venlafaxine—SLC6A3—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00107	0.0135	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.0133	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00106	0.0133	CbGpPWpGaD
Venlafaxine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00103	0.0198	CbGeAlD
Venlafaxine—SLC6A4—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.001	0.0127	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000981	0.0124	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000969	0.0122	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000961	0.0121	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000954	0.012	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.000947	0.0119	CbGpPWpGaD
Venlafaxine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000925	0.0178	CbGeAlD
Venlafaxine—SLC6A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.000909	0.0115	CbGpPWpGaD
Venlafaxine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000891	0.0171	CbGeAlD
Venlafaxine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.00087	0.0167	CbGeAlD
Venlafaxine—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.000863	0.0109	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000858	0.0108	CbGpPWpGaD
Venlafaxine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000856	0.0165	CbGeAlD
Venlafaxine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000848	0.0163	CbGeAlD
Venlafaxine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000848	0.0163	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00084	0.0106	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000823	0.0104	CbGpPWpGaD
Venlafaxine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000816	0.0157	CbGeAlD
Venlafaxine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.000776	0.00978	CbGpPWpGaD
Venlafaxine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000753	0.0145	CbGeAlD
Venlafaxine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000746	0.0143	CbGeAlD
Venlafaxine—ABCG2—midbrain—attention deficit hyperactivity disorder	0.000725	0.0139	CbGeAlD
Venlafaxine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000718	0.0138	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000718	0.00905	CbGpPWpGaD
Venlafaxine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000707	0.0136	CbGeAlD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000666	0.0084	CbGpPWpGaD
Venlafaxine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000648	0.0125	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00064	0.00807	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000627	0.00791	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000627	0.00791	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000582	0.00734	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000571	0.0072	CbGpPWpGaD
Venlafaxine—SLC6A2—brain—attention deficit hyperactivity disorder	0.00057	0.011	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000565	0.00712	CbGpPWpGaD
Venlafaxine—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.000561	0.0108	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000555	0.007	CbGpPWpGaD
Venlafaxine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00055	0.0106	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000548	0.00691	CbGpPWpGaD
Venlafaxine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000541	0.0104	CbGeAlD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000541	0.00682	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000539	0.0068	CbGpPWpGaD
Venlafaxine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000529	0.0102	CbGeAlD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000524	0.00661	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000515	0.0065	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000511	0.00644	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000509	0.00642	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000499	0.00629	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00049	0.00617	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000484	0.0061	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000474	0.00598	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000464	0.00586	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000464	0.00585	CbGpPWpGaD
Venlafaxine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000458	0.0088	CbGeAlD
Venlafaxine—ABCG2—brain—attention deficit hyperactivity disorder	0.000456	0.00876	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000449	0.00566	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000441	0.00557	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000436	0.0055	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000435	0.00548	CbGpPWpGaD
Venlafaxine—CYP2B6—brain—attention deficit hyperactivity disorder	0.00042	0.00808	CbGeAlD
Venlafaxine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000415	0.00798	CbGeAlD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000411	0.00519	CbGpPWpGaD
Venlafaxine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000409	0.00785	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000406	0.00512	CbGpPWpGaD
Venlafaxine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0004	0.00768	CbGeAlD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000397	0.005	CbGpPWpGaD
Venlafaxine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000393	0.00756	CbGeAlD
Venlafaxine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000384	0.00739	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00038	0.00479	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000371	0.00468	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000362	0.00456	CbGpPWpGaD
Venlafaxine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000358	0.00687	CbGeAlD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000356	0.00449	CbGpPWpGaD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000356	0.00448	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000354	0.00447	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000353	0.00445	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000342	0.00431	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000341	0.0043	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000336	0.00424	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000332	0.00419	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000332	0.00419	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000328	0.00414	CbGpPWpGaD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000327	0.00413	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000324	0.00409	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000322	0.00406	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000317	0.004	CbGpPWpGaD
Venlafaxine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000316	0.00398	CbGpPWpGaD
Venlafaxine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000312	0.006	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000309	0.0039	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000298	0.00376	CbGpPWpGaD
Venlafaxine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000294	0.00565	CbGeAlD
Venlafaxine—NPY1R—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000289	0.00365	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000288	0.00363	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000284	0.00359	CbGpPWpGaD
Venlafaxine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000283	0.00544	CbGeAlD
Venlafaxine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000277	0.00532	CbGeAlD
Venlafaxine—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000259	0.00327	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000256	0.00323	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000255	0.00321	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000251	0.00316	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000248	0.00312	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000246	0.0031	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000244	0.00308	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000244	0.00307	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000239	0.00301	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000236	0.00298	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00023	0.0029	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000227	0.00286	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000226	0.00285	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000225	0.00284	CbGpPWpGaD
Venlafaxine—ABCB1—brain—attention deficit hyperactivity disorder	0.000225	0.00432	CbGeAlD
Venlafaxine—NPY1R—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000223	0.00281	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000217	0.00273	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000215	0.00271	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000213	0.00269	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000213	0.00269	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000209	0.00264	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0002	0.00252	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000199	0.00251	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000198	0.0025	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000195	0.00246	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000195	0.00245	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000194	0.00245	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000193	0.00244	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000192	0.00242	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00019	0.0024	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.0024	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00019	0.00239	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000188	0.00237	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000186	0.00235	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000183	0.00231	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000181	0.00229	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000175	0.00221	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000175	0.0022	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000172	0.00218	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00017	0.00215	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000163	0.00206	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000162	0.00204	CbGpPWpGaD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000161	0.00203	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000159	0.002	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000152	0.00191	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00015	0.00189	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000149	0.00188	CbGpPWpGaD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000148	0.00187	CbGpPWpGaD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000147	0.00185	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000144	0.00181	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000132	0.00166	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000122	0.00154	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000115	0.00145	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000115	0.00145	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000114	0.00144	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000114	0.00144	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000113	0.00143	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000113	0.00142	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000111	0.0014	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000107	0.00135	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000104	0.00131	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000104	0.00131	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000103	0.0013	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.00129	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000101	0.00127	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.91e-05	0.00125	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.7e-05	0.00122	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.38e-05	0.00118	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.63e-05	0.00109	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.56e-05	0.00108	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.51e-05	0.00107	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	8.42e-05	0.00106	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.21e-05	0.00104	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.93e-05	0.001	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.88e-05	0.000993	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.86e-05	0.000992	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.82e-05	0.000987	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.81e-05	0.000985	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	7.77e-05	0.00098	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.76e-05	0.000978	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	7.42e-05	0.000935	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.69e-05	0.000843	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.57e-05	0.000828	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.37e-05	0.000803	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.19e-05	0.000654	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.15e-05	0.000649	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.12e-05	0.000645	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.67e-05	0.000589	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.4e-05	0.000554	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.4e-05	0.000554	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.32e-05	0.000545	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.02e-05	0.000507	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.62e-05	0.000456	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.53e-05	0.000445	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.51e-05	0.000443	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.48e-05	0.000439	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.44e-05	0.000434	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.35e-05	0.000422	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	3.32e-05	0.000419	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.24e-05	0.000409	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.22e-05	0.000406	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.22e-05	0.000406	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.22e-05	0.000406	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.17e-05	0.0004	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.95e-05	0.000372	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	2.66e-05	0.000336	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.64e-05	0.000333	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.58e-05	0.000325	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.45e-05	0.000309	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	2.43e-05	0.000307	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.43e-05	0.000307	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	2.4e-05	0.000302	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.38e-05	0.0003	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.38e-05	0.0003	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.34e-05	0.000295	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.000282	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.000282	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.23e-05	0.000281	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.22e-05	0.00028	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.22e-05	0.00028	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.2e-05	0.000278	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	2.18e-05	0.000275	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.17e-05	0.000274	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.12e-05	0.000267	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000258	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.03e-05	0.000256	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.95e-05	0.000246	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.95e-05	0.000245	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.94e-05	0.000244	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.9e-05	0.00024	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.85e-05	0.000234	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.81e-05	0.000228	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	0.000226	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.77e-05	0.000224	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.7e-05	0.000215	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.69e-05	0.000213	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.48e-05	0.000186	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.46e-05	0.000185	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.46e-05	0.000185	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.46e-05	0.000185	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.44e-05	0.000182	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.44e-05	0.000182	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.43e-05	0.00018	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.42e-05	0.000179	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	0.000171	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	0.00017	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.35e-05	0.00017	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.34e-05	0.000169	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.34e-05	0.000168	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.3e-05	0.000163	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	0.000148	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	1.14e-05	0.000144	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	0.000141	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.87e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.81e-06	0.000111	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	8.37e-06	0.000106	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	6.33e-06	7.98e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.17e-06	7.79e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.82e-06	7.34e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.77e-06	7.27e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.8e-06	4.8e-05	CbGpPWpGaD
